Anti-Inflammatory Treatments for Major Depressive Disorder: What's on the Horizon?

J Clin Psychiatry. 2019 Jun 25;80(6):18ac12630. doi: 10.4088/JCP.18ac12630.

Author

Manish Kumar Jha^{1

2

3}

Affiliations

¹ Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, Box 1230, New York, NY 10029. manish.jha@mssm.edu.
² Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
³ Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas, USA.

PMID: 31237996
DOI: 10.4088/JCP.18ac12630

No abstract available

MeSH terms

Anti-Inflammatory Agents / adverse effects
Anti-Inflammatory Agents / therapeutic use*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Antidepressive Agents / adverse effects
Antidepressive Agents / therapeutic use
Clinical Trials as Topic
Cytokines / antagonists & inhibitors
Depressive Disorder, Major / drug therapy*
Dietary Supplements
Drug Therapy, Combination
Forecasting
Humans
Surveys and Questionnaires

Substances

Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents
Cytokines